Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers

N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as σ receptor ligands with potential neuroprotective effects

(2013) Samuel D. Banister et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Triquinane scaffolds: Shape and geometry as a function of saturation and bridgehead groups

(2013) Lois-May Young et al.   JOURNAL OF MOLECULAR STRUCTURE

A σ1 receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ols (AHDs)

(2012) Samuel D. Banister et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Polycyclic Cage Structures as Lipophilic Scaffolds for Neuroactive Drugs

(2012) Jacques Joubert et al.   ChemMedChem

The emergence of designed multiple ligands for neurodegenerative disorders

(2011) Werner J. Geldenhuys et al.   PROGRESS IN NEUROBIOLOGY

The use of multi-target drugs in the treatment of neurodegenerative diseases

(2011) Cornelis J Van der Schyf   Expert Review of Clinical Pharmacology

L-Type Calcium Channel Blockers: From Diltiazem to 1,2,4-Oxadiazol-5-ones via Thiazinooxadiazol-3-one Derivatives

(2009) Roberta Budriesi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hexabromocyclododecane Inhibits Depolarization-Induced Increase in Intracellular Calcium Levels and Neurotransmitter Release in PC12 Cells

(2008) Milou M. L. Dingemans et al.   TOXICOLOGICAL SCIENCES

Neuroprotection in mice by NGP1-01 after transient focal brain ischemia

(2007) Jiukuan Hao et al.   BRAIN RESEARCH